ID

33443

Beskrivning

Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease Progression; ODM derived from: https://clinicaltrials.gov/show/NCT02431169

Länk

https://clinicaltrials.gov/show/NCT02431169

Nyckelord

Versioner (1)
  1. 2018-12-09 2018-12-09 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

9 december 2018

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Carcinoma, Non-Small-Cell-Lung NCT02431169

Engelsk

Eligibility Carcinoma, Non-Small-Cell-Lung NCT02431169

1 Formulär  
Criteria
Beskrivning

Criteria

diagnosis of metastatic stage iiib/iv lung adenocarcinoma
Beskrivning

LUNG CANCER ADENOCARCINOMA METASTATIC TNM clinical staging

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0746071
UMLS CUI [1,2]
C3258246
presence of known sensitizing mutations in egfr tk domain (exon 19 deletion and l858r)
Beskrivning

Epidermal Growth Factor Receptor Mutation | EGFR exon 19 deletion | EGFR Exon 21 L858R Mutation

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0034802
UMLS CUI [1,2]
C0026882
UMLS CUI [2]
C3889117
UMLS CUI [3]
C3274204
absence of known resistant mutations in the egfr tk domain (t790m)
Beskrivning

Absence Epidermal Growth Factor Receptor Mutation Resistant | EGFR T790M

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0034802
UMLS CUI [1,3]
C0026882
UMLS CUI [1,4]
C0332325
UMLS CUI [2]
C3274192
consented to hrpo# 201305031 ("tissue and blood acquisition for genomic analysis and collection of health information from patients with thoracic malignancies, suspected thoracic malignancies, or mesothelioma")
Beskrivning

Consent Clinical Trial Specified

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1511481
UMLS CUI [1,2]
C0008976
UMLS CUI [1,3]
C0205369
up to one prior line of systemic treatment for this malignancy
Beskrivning

Systemic therapy Malignant Neoplasms

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C0006826
no prior localized therapy to the biopsy site
Beskrivning

Absence Localized Therapy Biopsy site

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C1517925
UMLS CUI [1,3]
C1301128
planned treatment with standard of care erlotinib
Beskrivning

Erlotinib Standard of Care Planned

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1135135
UMLS CUI [1,2]
C2936643
UMLS CUI [1,3]
C1301732
not pregnant or breastfeeding
Beskrivning

Pregnancy Absent | Breast Feeding Absent

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0006147
UMLS CUI [2,2]
C0332197
at least 18 years of age
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
able to understand and willing to sign a written informed consent document
Beskrivning

Informed Consent

Datatyp

boolean

Alias
UMLS CUI [1]
C0021430
Tillbaka till toppen

Similar models

Eligibility Carcinoma, Non-Small-Cell-Lung NCT02431169

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
LUNG CANCER ADENOCARCINOMA METASTATIC TNM clinical staging
Item
diagnosis of metastatic stage iiib/iv lung adenocarcinoma
boolean
C0746071 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Epidermal Growth Factor Receptor Mutation | EGFR exon 19 deletion | EGFR Exon 21 L858R Mutation
Item
presence of known sensitizing mutations in egfr tk domain (exon 19 deletion and l858r)
boolean
C0034802 (UMLS CUI [1,1])
C0026882 (UMLS CUI [1,2])
C3889117 (UMLS CUI [2])
C3274204 (UMLS CUI [3])
Absence Epidermal Growth Factor Receptor Mutation Resistant | EGFR T790M
Item
absence of known resistant mutations in the egfr tk domain (t790m)
boolean
C0332197 (UMLS CUI [1,1])
C0034802 (UMLS CUI [1,2])
C0026882 (UMLS CUI [1,3])
C0332325 (UMLS CUI [1,4])
C3274192 (UMLS CUI [2])
Consent Clinical Trial Specified
Item
consented to hrpo# 201305031 ("tissue and blood acquisition for genomic analysis and collection of health information from patients with thoracic malignancies, suspected thoracic malignancies, or mesothelioma")
boolean
C1511481 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
C0205369 (UMLS CUI [1,3])
Systemic therapy Malignant Neoplasms
Item
up to one prior line of systemic treatment for this malignancy
boolean
C1515119 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
Absence Localized Therapy Biopsy site
Item
no prior localized therapy to the biopsy site
boolean
C0332197 (UMLS CUI [1,1])
C1517925 (UMLS CUI [1,2])
C1301128 (UMLS CUI [1,3])
Erlotinib Standard of Care Planned
Item
planned treatment with standard of care erlotinib
boolean
C1135135 (UMLS CUI [1,1])
C2936643 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,3])
Pregnancy Absent | Breast Feeding Absent
Item
not pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Age
Item
at least 18 years of age
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
able to understand and willing to sign a written informed consent document
boolean
C0021430 (UMLS CUI [1])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial